Bivalent single-cycle vaccines against respiratory diseases

Research unit

INNOSUISSE

Project number

119.403 IP-LS

Project title

Bivalent single-cycle vaccines against respiratory diseases

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Biotechnology and processing
Abstract (English)	Building on our SARS-CoV-2 single-cycle vaccine success, we aim to leverage this breakthrough by targeting additional respiratory viruses of clinical concern. For this, we will create bivalent vaccines and aim for high efficacy and intranasal delivery to offer potent immunity.